Results of assessing the safety and efficacy of Vegakiss phase 2 drug in treating HIV / AIDS-infected patients

Vegakiss is a state-level scientific project: 'Assessing the safety and efficacy of treatment of Vegakiss in patients infected with HIV / AIDS' conducted by the Institute for Treatment of Critical Illnesses.

Vegakiss was evaluated by the Ministry of Health for safety on 20 volunteers who voluntarily took 3 or 4 Vegakiss tablets of 500mg / day on two groups, each of 10 people in 1 month. The results showed that Vegakiss drug did not cause unwanted side effects for users, besides the drug also works to help people eat well, sleep well and gain weight. According to the decision of the Ministry of Health, Vegakiss medicine was recently evaluated in Phase II of over 60 voluntary HIV / AIDS patients, divided into two groups of 30 people each:

Group I: Using Vegakiss drug to treat HIV / AIDS Patients for 3 months. The results showed that during the 3 months of treatment:

* For HIV patients:
Reducing a clinical symptom, no new symptoms appear during treatment. Patients taking Vegakiss increased 1.33 kg, BMI increased 0.46 kg / m ² , patients slept well and gained weight. Vegakiss does not affect the indicators of the patient's blood. The post-treatment viral concentration is 60% above 104.

* For AIDS patients:
Vegakiss is effective in reducing some clinical symptoms in AIDS patients, no new symptoms appear. Patients increased by 1kg, BMI increased by 0.23kg / m ² . TCD index increased from 123.67 TB / mm ^{3 of} blood to 254.47 TB / mm3 of blood. Viral concentration decreased significantly 73.3% with P> 0.05. Vegakiss does not affect and change blood parameters because the medicine is made from herbs.
- The urine indicators of HIV / AIDS patients do not change between the two groups before and after treatment.
- Side effects for patients taking Vegakiss: Slight appearance, occasional dizziness symptoms, dizziness, mild numbness. These symptoms will go away quickly after 10-15 minutes without treatment

** Conclude:
- Vegakiss drugs have the effect of reducing clinical symptoms for HIV-infected patients, with immunodeficiency and AIDS patients.
- Helping patients to eat, sleep well, gain weight.
- Patients do not appear new symptoms during treatment.
- Red blood cells of patients taking normal Vegakiss, urine unchanged.
After the second stage of treatment, compared to patients with HIV / AIDS using pharmaceutical chemistry, patients taking Vegakiss have better health.
- TCD index increased to 254.47 TB / mm ³
- Viral concentration significantly decreased 73.3% with P.0.05
- Vegakiss does not affect and change blood parameters because it is made from herbs.
- No side effects of patients taking Vegakiss.

Group II: 30 patients with HIV / AIDS using drugs for pharmaceutical chemistry, according to the ARV guidelines issued by the Ministry of Health (Stavudin (d4T) 30mg x 2 tablets / day, divided into 2 doses. mg x 2 capsules / day, divided into 2 doses Nevirapine 200 mg x 1 tablet / day x 2 weeks, after 2 tablets / day, divided into 2 doses. 3 months of treatment The results showed that during 3 months of treatment:

* For HIV patients:
Relieved does not appear new symptoms: thinning, enlarged lymph nodes. Patients gaining weight less than 0.47kg, BMI increased 0.13kg / m ² , 33.3% of patients increased by more than 1 kg. The concentration of virus after treatment decreased to 26.6%. The number of erythrocytes in Chemical group decreased significantly with P <0.05.

* For AIDS patients:
The rate of skin infection is 20%, there is no new clinical symptom, reducing some clinical symptoms in AIDS patients. Patients gained weight 0.44kg and BMI increased by 0.13kg / m ² , patients increased by 1kg 26.6%. The TCD index increased by 274.67 TB / mm ^{3 of} blood. Viral concentration decreased significantly by 90% with P> 0.05.
- The urine indicators of HIV / AIDS patients do not change between the two groups before and after treatment.
- Side effects such as fatigue, rash, insomnia, itching, loss of appetite, nausea and vomiting, headache .

**Conclude:
- Medicinal drugs have the effect of reducing clinical symptoms for HIV-infected patients, have reduced immunity and AIDS patients.
- Effective to help patients gain light weight.
- Patients do not appear new symptoms during treatment.
- Red blood cells of patients using chemotherapy decreased markedly with P <0.05, normally, urine did not change.

Comment on the safety and efficacy of Vegakiss and pharmaco-chemical drugs in support of HIV / AIDS treatment:

* Treatment effect:
+ There is no difference in immune resilience for HIV / AIDS-infected patients between the two groups, with P> 0.05
+ The ability to inhibit the development of HIV Virus: Quantitative results of HIV virus by PCR method in China before and after 3 months of treatment for both groups, the results showed that the ability to inhibit and do Reducing the concentration of HIV virus in both groups was no difference between the two groups with P> 0.05.

*Security:
- Since Vegakiss was studied and made entirely of herbs, Vegakiss had no or few side effects at the dose, if there were dizziness, fatigue, nausea, and numbness with frequency output from 7-16%. These symptoms are transient and do not require treatment.